Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Cerus (NASDAQ:CERS) reported quarterly earnings of $0.00 per share which beat the analyst consensus estimate of $(0.03) by 103....
Cerus (NASDAQ:CERS) raises FY2025 sales outlook from $200.000 million-$203.000 million to $202.000 million-$204.000 million vs ...
Cerus Corporation (NASDAQ:CERS) announced today the publication of a new recommendation from the German National Blood Advisory...
Cerus (NASDAQ:CERS) raises FY2025 sales outlook from $194.00 million-$200.00 million to $200.00 million-$203.00 million vs $213...
Cerus (NASDAQ:CERS) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is unchanged ...
Additional Funding to Support Randomized Study Evaluating Earlier Access to INTERCEPT Fibrinogen Complex in Trauma Associated H...
